Antitumor Activity ofFicus deltoideaExtract on Oral Cancer: An In Vivo Study
Open Access
- 10 February 2020
- journal article
- research article
- Published by Wiley in Journal of Oncology
- Vol. 2020, 1-10
Abstract
Background. The aim of this study is to evaluate the chemopreventive and chemotherapeutic activities ofFicus deltoidea(FD) in an animal model induced for oral cancer using 4-nitroquinoline-1-oxide (4NQO).Methods. Male Sprague-Dawley (SD) rats were randomized into six groups (n = 7 per group): Group 1 (untreated group); Group 2 (control cancer group) received 4NQO only for 8 weeks in their drinking water; Groups 3 and 4 (chemopreventive) received 4NQO for 8 weeks and were simultaneously treated with FD extract at 250 and 500 mg/kg, respectively, by oral gavage; Groups 5 and 6 (chemotherapeutic) received 4NQO for 8 weeks followed by the administration of FD extract at 250 and 500 mg/kg, respectively, for another 10 weeks. The incidence of oral cancer was microscopically evaluated. Moreover, immunohistochemical expression was analysed in tongue specimens using an image analyser computer system, while the RT2profiler PCR array method was employed for gene expression analysis.Results. The results of the present study showed a beneficial regression effect of the FD extract on tumor progression. The FD extract significantly reduced the incidence of oral squamous cell carcinoma (OSCC) from 100% to 14.3% in the high-dose groups. The immunohistochemical analysis showed that the FD extract had significantly decreased the expression of the key tumor marker cyclin D1 and had significantly increased the expression of theβ-catenin and e-cadherin antibodies that are associated with enhanced cellular adhesion. Based on the gene expression analysis, FD extract had reduced the expression of theTWIST1andRAC1genes associated with epithelial-mesenchymal transition (EMT) and had significantly downregulated theCOX-2andEGFRgenes associated with cancer angiogenesis, metastasis, and chemoresistance. Our data suggest that the FD extract exerts chemopreventive and chemotherapeutic activities in an animal model induced for oral cancer using 4NQO, thus having the potential to be developed as chemopreventive and chemotherapeutic agents.Keywords
Funding Information
- Ministry of Education Malaysia (PG 253-2015 B)
- Universiti Malaya (PG 253-2015 B)
This publication has 60 references indexed in Scilit:
- Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinomaWorld Journal of Surgical Oncology, 2012
- Cyclin D1 Expression and Its Correlation with Histopathological Differentiation in Oral Squamous Cell CarcinomaThe Scientific World Journal, 2012
- Zinc supplementation suppresses 4-nitroquinoline 1-oxide-induced rat oral carcinogenesisCarcinogenesis, 2011
- Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral CancerCancer Prevention Research, 2010
- Overexpression of Cyclooxygenase-2 in Rat Oral Cancers and Prevention of Oral Carcinogenesis in Rats by Selective and Nonselective COX InhibitorsCancer Prevention Research, 2010
- Suppression of Cancer Cell Growth by Promoting Cyclin D1 DegradationMolecular Cell, 2009
- Reported analgesic and anaesthetic administration to rodents undergoing experimental surgical proceduresLaboratory Animals, 2009
- Cyclin D1 overexpression increases susceptibility to 4‐nitroquinoline‐1‐oxide‐induced dysplasia and neoplasia in murine squamous oral epitheliumMolecular Carcinogenesis, 2009
- Molecular biology of squamous cell carcinoma of the head and neckJournal of Clinical Pathology, 2006
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005